fluoxetine has been researched along with cannabidiol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dutour, R; Poirier, D | 1 |
| Crestani, CC; Guimarães, FS; Joca, SRL; Sales, AJ | 1 |
| Ajdary, M; Akhavan Tavakoli, M; Marzban, H; Mehdizadeh, M; Moradi, F; Shabani, R; Soleimani, M | 1 |
| Buchalter, DB; Dankert, JF; Ihejirika, Y; Ihejirika-Lomedico, R; Kirby, DJ; Leucht, P; Mehta, D; Muiños-López, E; Patel, K | 1 |
2 review(s) available for fluoxetine and cannabidiol
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
4 other study(ies) available for fluoxetine and cannabidiol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels.
Topics: Animals; Antidepressive Agents; Brain; Cannabidiol; Depressive Disorder; Desipramine; Disease Models, Animal; Drug Synergism; Fluoxetine; Male; Mice; Norepinephrine; Random Allocation; Serotonin | 2018 |
Autophagic Molecular Alterations in the Mouse Cerebellum Experimental Autoimmune Encephalomyelitis Model Following Treatment with Cannabidiol and Fluoxetine.
Topics: Animals; Autophagy; bcl-2-Associated X Protein; Cannabidiol; Cerebellum; Encephalomyelitis, Autoimmune, Experimental; Female; Fluoxetine; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases | 2023 |
Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells.
Topics: Animals; Cannabidiol; Cell Proliferation; Cell Survival; Fluoxetine; Gene Expression; Humans; Mesenchymal Stem Cells; Mice; Models, Animal; Osteoporosis | 2023 |